LY3451838
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LY3451838, covering 2023-11-28 to 2025-09-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study of LY3451838 in Healthy Participants [Phase 1]